Related Experiment Video
Updated: Nov 21, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
The role of rotational thromboelastometry during the COVID-19 pandemic: a narrative review
Klaus Görlinger1,2, Hawra Almutawah3, Fatimah Almutawaa3
1Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Insights
Rotational thromboelastometry (ROTEM®) aids in detecting COVID-19 coagulopathy, offering a comprehensive view beyond standard tests. Combining ROTEM® with standard coagulation tests improves patient monitoring and treatment guidance for better outcomes.
Area of Science:
- Hematology
- Infectious Diseases
- Critical Care Medicine
Background:
- COVID-19 is a global health crisis linked to hypercoagulability and fatal thromboembolic events.
- Standard coagulation tests (SCT) often fail to detect COVID-19-associated hypercoagulability.
- Viscoelastic tests like ROTEM® offer a more comprehensive assessment of coagulation status.
Purpose of the Study:
- To review the role of rotational thromboelastometry (ROTEM®) in managing COVID-19-associated coagulopathy.
- To explore how ROTEM® parameters can characterize coagulation abnormalities in COVID-19 patients.
- To assess the utility of ROTEM® in guiding anticoagulant therapy and improving patient outcomes.
Main Methods:
- Review of published literature on ROTEM® and COVID-19 coagulopathy.
- Analysis of ROTEM® parameters in relation to hypercoagulability and hypocoagulability.
- Comparison of ROTEM® with standard coagulation tests (SCT) for COVID-19 patients.
Main Results:
- COVID-19 coagulopathy, assessed by ROTEM®, can range from hypercoagulability to hypocoagulability.
- ROTEM® provides detailed information on individual coagulation status and dynamic changes.
- Combining ROTEM® with SCT (e.g., fibrinogen, D-dimer) aids in detecting hemostasis issues.
Conclusions:
- A multimodal diagnostic approach using ROTEM® and SCT is recommended for COVID-19 patients.
- ROTEM® aids in guiding anticoagulant therapy and potentially improving outcomes.
- Further research is needed to establish evidence-based guidelines for ROTEM® use in COVID-19.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic is currently recognized as a global health crisis. This viral infection is frequently associated with hypercoagulability, with a high incidence of thromboembolic complications that can be fatal. In many situations, the standard coagulation tests (SCT) fail to detect this state of hypercoagulability in patients with COVID-19 since clotting times are either not or only mildly affected. The role of viscoelastic tests such as rotational thromboelastometry (ROTEM®) during this pandemic is explored in this review. COVID-19-associated coagulopathy, as measured using the rotational thromboelastometry parameters, can vary from hypercoagulability due to increased fibrin polymerization and decreased fibrinolysis to bleeding from hypocoagulability. The use of a multimodal diagnostic and monitoring approach, including both rotational thromboelastometry and SCT, such as plasma fibrinogen and D-dimer concentrations, is recommended. Rotational thromboelastometry provides comprehensive information about the full coagulation status of each patient and detects individual variations. Since COVID-19-associated coagulopathy is a very dynamic process, the phenotype can change during the course of infection and in response to anticoagulation therapy. Data from published literature provide evidence that the combination of rotational thromboelastometry and SCT analysis is helpful in detecting hemostasis issues, guiding anticoagulant therapy, and improving outcomes in COVID-19 patients. However, more research is needed to develop evidence-based guidelines and protocols.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction

